Advanced Medical Solutions Group (LON:AMS)‘s stock had its “hold” rating reaffirmed by equities researchers at Numis Securities in a note issued to investors on Wednesday. They presently have a GBX 275 ($3.80) target price on the stock. Numis Securities’ price objective points to a potential downside of 17.29% from the company’s current price.

Shares of Advanced Medical Solutions Group (LON AMS) opened at GBX 332.50 ($4.59) on Wednesday. The firm has a market cap of $700.67 and a price-to-earnings ratio of 4,156.25. Advanced Medical Solutions Group has a one year low of GBX 233 ($3.22) and a one year high of GBX 351 ($4.85).

COPYRIGHT VIOLATION WARNING: “Numis Securities Reiterates “Hold” Rating for Advanced Medical Solutions Group (AMS)” was published by Daily Political and is the property of of Daily Political. If you are reading this piece on another site, it was illegally stolen and republished in violation of U.S. and international trademark & copyright laws. The legal version of this piece can be viewed at https://www.dailypolitical.com/2018/03/14/numis-securities-reiterates-hold-rating-for-advanced-medical-solutions-group-ams.html.

Advanced Medical Solutions Group Company Profile

Advanced Medical Solutions Group plc is engaged in the design, development, manufacture and distribution of materials for use in advanced woundcare products and surgical dressings, as well as medical adhesives and sutures for closing and sealing tissue. It operates through four segments: Branded Direct, Branded Distributed, OEM (Original Equipment Manufacturer) and Bulk Materials.

Analyst Recommendations for Advanced Medical Solutions Group (LON:AMS)

Receive News & Ratings for Advanced Medical Solutions Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Medical Solutions Group and related companies with MarketBeat.com's FREE daily email newsletter.